“In addition to protecting people’s health, the government must maintain the country’s viability, which is why it’s important to support companies that start and implement new investments,” said Minister of Foreign Affairs and Trade Péter Szijjártó.
The Hungarian state will provide direct state support of EUR 4 million toward the pharmaceutical investment, with which Sanofi will install a new, high-speed, pre-filled sterile syringe production line at its plant in Csanyikvölgy, Miskolc, the minister added.
The Hungarian pharmaceutical industry has doubled its exports since 2010, and companies in this sector spend the most, in proportion to revenues, on research and development.
In Csanyikvölgy, ampoules and aseptically prepared pre-filled syringe injections are manufactured using world-class technology. The plant maintains a high level of manufacturing safety and a completely sterile environment and employs nearly 400 well-trained professionals, making it one of the largest employers in northeast Hungary.
“Sanofi is committed to Hungary over the long term. The continuous development of the Csanyikvölgy plant and the investments here date back more than 30 years.”
In recent years, the company’s investments have totaled more than HUF 24 billion, making the site one of the most modern injection plants in Europe.
Almost HUF 90 billion worth of sterile injectable preparations are produced here every year, about 95 percent of which are exported to markets in 65 countries.
The anticoagulants prepared on the new line may appear in Hungary and on foreign markets by April 2022.